Photo from wikipedia
The human microbiota may contribute to atherosclerotic cardiovascular disease (ASCVD) through the production of trimethylamine-N-oxide (TMAO), a gut microbiota-dependent metabolite previously implicated in atherosclerosis. Prior studies suggest that TMAO levels… Click to show full abstract
The human microbiota may contribute to atherosclerotic cardiovascular disease (ASCVD) through the production of trimethylamine-N-oxide (TMAO), a gut microbiota-dependent metabolite previously implicated in atherosclerosis. Prior studies suggest that TMAO levels predict future ASCVD events in high
Keywords:
oxide related;
cardiovascular events;
associated cardiovascular;
related metabolites;
trimethylamine oxide;
metabolites associated
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!